The landscape of at-home diagnostic testing has transformed dramatically from a budding trend before the pandemic to a rapidly growing segment in the health product market. This surge was significantly catalyzed by the widespread adoption of over-the-counter (OTC) COVID-19 rapid antigen tests, allowing individuals to conduct self-testing within the comfort of their homes. The shift towards this form of testing has not only changed consumer behavior but has established a new norm in health management.
Even with the prevalence of COVID-19 infections that initially fueled this trend, the demand remains substantial. At a recent diagnostics summit, Jack Meehan, a health care equity analyst from Nephron Research, highlighted that the market for endemic COVID-19 at-home testing is projected to be two to three times larger than the pre-pandemic flu testing market, which stood around $1.5 billion. This statistic reinforces the notion that at-home diagnostics present a significant opportunity for pharmacy growth.
The data strongly supports the idea that the OTC at-home diagnostics market is on an upward trajectory. Recent analyses suggest that the At-Home Testing Kits Market will experience a compound annual growth rate (CAGR) of 6.1% from 2022 to 2029, with some estimates even reaching as high as 11.3%. This growth trend indicates a shift in consumer preferences towards more convenient health solutions.
By capitalizing on the momentum created by the do-it-yourself testing boom, community-based and retail pharmacies have the potential to fortify their roles as essential health care hubs. Implementing a category management strategy that enhances consumer experiences can significantly improve both store relevance and profitability.
Navigating the New Era of Health Care Consumerism Driven by COVID-19
The last two years have fundamentally altered consumer perceptions regarding at-home diagnostics and the essential nature of rapid testing. Dr. Wilbur Lam, a professor of Biomedical Engineering at Emory University and Georgia Tech, noted the significant cultural shift among the public regarding testing accessibility and reliability.
Dr. Lam’s research team has played a pivotal role in evaluating the quality of COVID-19 diagnostics for the NIH. He emphasizes that prior to the pandemic, at-home testing options were severely limited, allowing only for blood sugar or pregnancy tests. However, the pandemic has illuminated the potential for diagnosing infections from home, thus broadening the scope of self-testing.
The pandemic has heightened consumer awareness regarding the critical role that testing plays in health management. Lockdowns and movement restrictions further emphasized the necessity of telemedicine and alternative care settings, such as the home. Michael Abrams, managing partner at Numerof & Associates, pointed out that the emergence of the Omicron variant at the end of 2021 led to a surge in infections and a pressing need for accessible testing solutions.
This sudden demand effectively dismantled previous hesitations surrounding at-home testing, which had been perceived as a novel yet unnecessary technology. The FDA’s emergency use authorization of at-home tests catalyzed this transition, leading to a rapid increase in available products. By the end of the first quarter of 2022, there were 16 at-home diagnostic products on the market, signifying a substantial shift in consumer behavior.
Moreover, the pandemic has fostered a new generation of health-conscious consumers who are eager to take control of their health care decisions. The Kaufman Hall State of the Healthcare Consumer Report 2022 reveals insights from over 3,500 Americans, highlighting evolving consumer engagement with health services, particularly among those under 45 years of age.
These younger consumers are not only investing more in their health care but are also actively seeking out services such as mental health support, fitness tracking, and alternative therapies like cryotherapy and acupuncture. Abrams comments on this trend, noting that younger individuals are particularly motivated to engage in their health and utilize at-home testing to gain concrete insights into their well-being.
Today’s digitally savvy health care consumers are increasingly comfortable with online research, communication with health professionals, and health management through digital platforms. Their willingness to embrace telehealth further demonstrates an openness to innovative health care solutions that prioritize convenience and personal control.
As consumers become more adept at leveraging rapidly evolving technologies for tracking, diagnosing, and managing health, the movement towards do-it-yourself at-home testing has gained momentum. Recent data from Deloitte indicates that 30% to 50% of consumers are now comfortable using at-home diagnostic tools.
In this evolving landscape, the role of pharmacies is expanding beyond merely dispensing prescriptions.
Christopher Lis, managing director of Global Healthcare Intelligence at J.D. Power, emphasizes that customers are increasingly viewing their retail pharmacies as comprehensive health and wellness service hubs. This trend presents a significant opportunity for pharmacies to innovate and adapt to the changing consumer landscape.
The rise of health care consumerism, coupled with the decentralization of health services and the democratization of diagnostics, has positioned pharmacies to emerge as primary retail centers for at-home health diagnostic solutions.
Identifying and Addressing Gaps in Retail Management of At-Home Testing
Despite the favorable market conditions for self-test products, the rapid growth of at-home diagnostics has exposed several gaps in retail management practices. A lack of insight into consumer buying behavior hampers effective strategy development.
During the pandemic, sales of COVID-19 test kits were not driven by an understanding of consumer segmentation or behaviors; rather, they were characterized by a uniform approach of simply fulfilling orders without targeted marketing efforts. Now that the pandemic has transitioned to an endemic phase, the industry must address crucial questions regarding consumer motivation for utilizing these products and the channels through which they will seek at-home diagnostic tools moving forward.
Another pressing concern is the confusion surrounding the use of at-home diagnostic products and the interpretation of results.
Dr. Lam notes that health care providers often express skepticism about the reliability of data submitted by patients. While it’s acknowledged that tests may not be flawless, there is a collective understanding that the benefits of self-testing far outweigh the potential drawbacks.
It is essential for pharmacies, health care providers, and consumers to receive education on the appropriate use of self-testing, the interpretation of results, and the subsequent steps to take. This represents a critical opportunity for pharmacies to enhance their roles as health care educators within their communities.
Additionally, the consumer experience surrounding self-testing remains incomplete. Locating tests within pharmacies can be a frustrating endeavor. The issue is no longer that only select pharmacies carry COVID-19 tests; rather, there is inconsistency in product placement. Some pharmacies display tests behind locked cases, others behind pharmacy counters, while some group them with respiratory products.
Furthermore, obtaining the test itself is just one aspect of the solution. A standalone healthcare diagnostic product does not fully address the consumer’s health concerns. To maximize the value of self-testing, retail pharmacies need to develop integrated, end-to-end services that offer a comprehensive experience, including diagnosis, advice, and follow-up feedback. Retailers should also consider bundling tests with complementary products and services for a more cohesive offering.
For example, a pharmacy that provides test-to-treat options exemplifies a more holistic approach to customer service. When someone tests positive for COVID-19, they may be eligible for Paxlovid, which can alleviate symptoms and shorten the duration of illness. Forward-thinking pharmacies and diagnostic providers are integrating the test-to-treat experience through digital platforms to capture, monitor, and relay information to primary care providers, health departments, and other relevant parties.
“Simply offering a test that indicates a positive or negative result is no longer sufficient,” states Paul Schrimpf, Partner and Strategic Advisor at Prophet Healthcare. “However, enabling patients to upload results or link them to their medical records represents a significant innovation in the at-home diagnostics space.”
Maximizing Opportunities for Retail Pharmacies in the At-Home Diagnostics Market
The growth in the self-testing market has empowered consumers with greater diagnostic literacy. As a result, retail pharmacies find themselves in a prime position to capture market share by strategically preparing for future demands. Here are several actionable strategies to optimize the benefits stemming from the growing trend of at-home diagnostics.
1. Implement a Comprehensive Category Management Approach
Just as the oral care category evolved from a limited selection of toothbrushes and toothpastes to a diverse range of products, the COVID-19 at-home diagnostic tests could serve as the foundation for an expanded retail category. The demand for at-home testing surged over the past two years, and even as COVID-19 transitions into an endemic phase, the need for diagnostics will remain significant.
A key step for pharmacies in enhancing their diagnostics category is to merchandise COVID-19 at-home test kits more thoughtfully and proactively. If consumers struggle to locate COVID-19 test kits easily, their confidence in returning for self-diagnostic solutions for other health conditions may wane.
In early 2023, one can expect an influx of at-home combined tests for COVID-19, flu, and RSV. The placement of these products on pharmacy shelves will be crucial. Multi-indicator tests targeting various diseases, including respiratory illnesses and STDs, are set to play an essential role in this emerging category.
“The bundling of tests will become increasingly common. The initial trigger for any test is often the feeling of illness. Consumers may not want to undergo multiple tests; instead, they’ll prefer a single test that provides a range of answers,” Schrimpf explains. “In terms of shelf space for at-home tests, I would recommend piloting different approaches. For instance, one store could have a dedicated at-home testing section, while another might place specific tests in condition-specific areas.”
2. Enhance Counseling and Educational Outreach
Hospitals have effectively implemented health education programs to support their communities, and pharmacies are similarly positioned to provide valuable insights related to diagnostic testing through robust “know your health” education initiatives.
Empowering pharmacists to serve as reliable information sources and trusted advisors is vital for fostering effective health care consumerism and encouraging appropriate usage of at-home diagnostics. Pharmacies can build their diagnostics category by facilitating counseling and education through written materials, personalized conversations, and community forums. This effort can help demystify testing procedures and guide customers on interpreting results and determining the next steps.
3. Offer Comprehensive Solutions to Consumer Health Needs
When individuals visit a pharmacy to purchase a diagnostic solution, it’s crucial to understand the underlying problem they are attempting to solve. While the immediate goal may be to identify a specific illness, the broader concern typically revolves around their overall health and recovery.
To truly address consumer needs, pharmacies should strive to provide complete solutions that encompass all elements from diagnosis through treatment. For example, COVID-19 test-to-treat solutions that integrate diagnostic testing with telemedicine consultations and prescription medications signify a comprehensive approach to health care.
“It’s essential to connect testing with telehealth services, ensuring easy access to the necessary counseling that individuals require. This integration can significantly benefit consumers by assisting them in navigating the results of their self-administered tests and making informed decisions,” Abrams states.
Rather than merely selling isolated products, pharmacies that can effectively link at-home diagnostics to comprehensive solutions—potentially in partnership with complementary service providers—will be better positioned to build revenue in the diagnostics sector.
4. Prepare for Rapid Market Changes and Innovations
Pharmacies are uniquely equipped to leverage the growth of the at-home diagnostics category. Analysts predict that retail and online pharmacies will collectively capture nearly 60% of the revenue share in this market. Community-based and retail pharmacies that lead the charge in at-home testing can diversify their offerings and further solidify their roles in the evolving healthcare landscape.
However, pharmacies must remain vigilant regarding the emergence of disruptive diagnostic technologies and competitive threats. Amazon’s aggressive entry into the healthcare sector—including initiatives like Amazon Clinic and digital pharmacy services—has already begun promoting at-home testing solutions. The critical question is whether pharmacies can adapt quickly enough to navigate these significant shifts.
“Survival in the at-home diagnostics space hinges on adaptability—the ability of pharmacies and diagnostic manufacturers to swiftly respond to a rapidly changing market,” asserts Dr. Wilbur Lam.
About the Author
Doug Field is the Chief Revenue Officer of PHASE Scientific Americas, a rapidly growing health diagnostics provider. He previously founded The Institute for HealthCare Consumerism and co-founded Employee Benefits News.
References
Clarin, D. (2022, September). 2022 State of the Healthcare Consumer Report. Kaufman, Hall & Associates, LLC. https://www.kaufmanhall.com/sites/default/files/2022-10/KH-SOC-2022-Report-V2.pdf
Federal Food and Drug Administration. (2022, May 16). Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test Available without a Prescription That Also Detects Flu and RSV. FDA. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-covid-19-test-available-without-prescription-also
Future Market Insights. (2022, April 15). Self-Testing Market is Set to Experience a Significant Growth of 5.5% CAGR From 2020 To 2030. FMI. https://www.biospace.com/article/self-testing-market-is-set-to-experience-a-significant-growth-of-5-5-percent-cagr-from-2020-to-2030-comprehensive-research-report-by-fmi/
Grove, A. (2022, June 15). How health care consumerism is reducing benefits costs for employers. San Antonio Business Journal. https://www.bizjournals.com/sanantonio/news/2022/06/15/health-care-consumerism-is-reducing-benefits-costs.html
Health Industry Distributors Association. (2022, July). COVID Testing Creates A New Educated Consumer. https://www.hidaams.org/distribution/news/healthcare-distribution-supply-chain-magazine/2022/covid-testing-creates-new-educated-consumer.aspx
J.D. Power (2022, July 28). Innovations at Retail Pharmacies Accelerate as Digital Competition, Health and Wellness Offerings Grow, J.D. Power Finds. J.D. Power. https://www.jdpower.com/business/press-releases/2022-us-pharmacy-study
Park, C. (2022, October 13). The post-pandemic future of diagnostics. Deloitte. https://www2.deloitte.com/us/en/blog/health-care-blog/2022/the-post-pandemic-future-of-diagnostics.html
Precedence Research. (n.d.). Home Diagnostics Market – Global Industry Analysis, 2022-2030. Precedence Research. https://www.precedenceresearch.com/home-diagnostics-market
Snyder, G., & Grand, P. (2021, September 23). Viewing MedTech through the lens of innovators. Deloitte. https://www2.deloitte.com/us/en/blog/health-care-blog/2021/viewing-medtech-through-the-lens-of-innovators.html
Sterrett, L. (2021, January 26). The road to DIY consumer health leads to the Future of Health. Deloitte. https://www2.deloitte.com/us/en/blog/health-care-blog/2021/road-to-diy-consumer-health.html
Sushant, T., & Onkar, S. (2022, February). Rapid Tests Market by Product, Application, and End User. Allied Market Research.https://www.alliedmarketresearch.com/rapid-tests-market
Tucker, J. D., Wedderburn, C. J., Yeung, S., & Peeling, R. W. (2021, December 7). Democratizing Diagnostics During COVID-19. PLOS. https://speakingofmedicine.plos.org/2021/12/07/democratizing-diagnostics-during-covid-19/